Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression

International Journal for Parasitology

Volumn 37, Issue 11, 2007, Pages 1243-1254

  Guiñazú, Natalia ^a   Pellegrini, Andrea ^a   Carrera Silva, Eugenio Antonio ^a   Aoki, Maria Pilar ^a   Cabanillas, Ana Maria ^a   Gìronés, Nuria ^b   Fresno, Manuel ^b   Cano, Roxana ^a   Gea, Susana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

IFN ; IL 12; Macrophage; Nitric oxide; Parasite

Indexed keywords

B7 ANTIGEN; CRUZIPAIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PARASITE ANTIGEN; REACTIVE NITROGEN SPECIES; TOLL LIKE RECEPTOR 2;

ANTIGEN; CHAGAS DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; NITRIC OXIDE; PARASITE; PROTEIN; TSETSE FLY;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTERFERON PRODUCTION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, CD80; BIOLOGICAL MARKERS; CHAGAS DISEASE; CYSTEINE ENDOPEPTIDASES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTOZOAN VACCINES; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 34547115710     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2007.03.010     Document Type: Article

References (44)

1. Aparicio I.M., Scharfstein J., and Lima A.P.C.A. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 72 (2004) 5892-5902
2. Bogdan C., Rollinghoff M., and Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 173 (2000) 17-26
3. Campos M.A.S., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Smith J.A., Golenbock D.T., and Gazzinelli R.T. Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 (2001) 416-423
4. Campos M.A., Closel M., Valente E.P., Cardoso J.E., Akira S., Alvarez-Leite J.I., Ropert C., and Gazzinelli R.T. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol. 172 (2004) 1711-1718
5. Cazzulo J., Stoka V., and Turk V. Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi. Biol. Chem. 378 (1997) 1-10
6. Chan E.D., Winston B.W., Uh S.-T., Wynes M.W., Rose D.M., and Riches D.W.H. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-{gamma} and TNF-{alpha} in mouse macrophages. J. Immunol. 162 (1999) 415-422
7. Cummings K.L., and Tarleton R.L. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect. Immun. 72 (2004) 4081-4089
8. Fernandez-Gomez R., Esteban S., Gomez-Corvera R., Zoulika K., and Ouaissi A. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J. Immunol. 160 (1998) 3471-3479
9. Flandin J., Chano F., and Descoteaux A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur. J. Immunol. 36 (2006) 411-420
10. Frank F., Petray P., Cazorla S., Munoz M., Corral R., and Malchiodi E. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes. Vaccine 22 (2003) 77-86
11. Giordanengo L., Maldonado C., Rivarola H., Iosa D., Girones N., Fresno M., and Gea S. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur. J. Immunol. 30 (2000) 3181-3189
12. Giordanengo L., Guinazu N., Stempin C., Fretes R., Cerban F., and Gea S. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 32 (2002) 1003-1011
13. Golgher D., and Gazzinelli R. Innate and acquired immunity in the pathogenesis of Chagas disease. Autoimmunity 37 (2004) 399-409
14. Grewal I., and Flavell R. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153 (1996) 85-106
15. Guinazu N., Pellegrini A., Giordanengo L., Aoki M., Rivarola H., Cano R., Rodrigues M., and Gea S. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice. Microbes Infect. 6 (2004) 1250-1258
16. Hoft D.F., and Eickhoff C.S. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect. Immun. 73 (2005) 4934-4940
17. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., and Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66 (1998) 1208-1215
18. Ke Y., Li Y., and Kapp J. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur. J. Immunol. 25 (1995) 549-553
19. Kopp E., and Medzhitov R. Recognition of microbial infection by toll-like receptors. Curr. Opin. Immunol. 15 (2003) 396-401
20. Linares E., Giorgio S., Mortara R.A., Santos C.X., Yamada A.T., and Augusto O. Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation. Free Radic. Biol. Med. 30 (2001) 1234-1242
21. Lund F., Garvy B., Randall T., and Harris D. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8 (2005) 25-54
22. Ma X., and Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79 (2001) 55-92
23. Martins G.A., Campanelli A.P., Silva R.B., Tadokoro C.E., Russo M., Cunha F.Q., Rizzo L.V., and Silva J.S. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection. Microbes Infect. 6 (2004) 1133-1144
24. Miller S., Ernst R., and Bader M. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3 (2005) 36-46
25. Mills C.D.K.K., Alt J.M., Heilman M.J., and Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164 (2000) 6166-6173
26. Miyahira Y., Katae M., Kobayashi S., Takeuchi T., Fukuchi Y., Abe R., Okumura K., Yagita H., and Aoki T. Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection. Infect. Immun. 71 (2003) 3131-3137
27. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 98 (2003) 577-591
28. Monteiro A.C., Schmitz V., Svensjo E., Gazzinelli R.T., Almeida I.C., Todorov A., de Arruda L.B., Torrecilhas A.C.T., Pesquero J.B., Morrot A., Bouskela E., Bonomo A., Lima A.P.C.A., Muller-Esterl W., and Scharfstein J. Cooperative activation of TLR2 and Bradykinin B2 receptor is required for induction of Type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J. Immunol. 177 (2006) 6325-6335
29. Munoz-Fernandez M.A., Fernandez M.A., and Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22 (1992) 301-307
30. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., Takayanagi H., Ohba Y., Taniguchi T., and Honda K. Evidence for licensing of IFN-{gamma}-induced IFN regulatory factor 1 transcription factor by MyD88 in toll-like receptor-dependent gene induction program. PNAS 103 (2006) 15136-15141
31. Netea M.G., van der Graaf C., Van der Meer J.W.M., and Kullberg B.J. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 75 (2004) 749-755
32. Netea M., Van der Meer J., and Kullberg B. Recognition of pathogenic microorganisms by toll-like receptors. Drugs Today (Barc) 42 Suppl A (2006) 99-105
33. Noel W., Raes G., Hassanzadeh Ghass G., De Baetselier P., and Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 20 (2004) 126-133
34. Ouaissi A., Guilvard E., Delneste Y., Caron G., Magistrelli G., Herbault N., Thieblemont N., and Jeannin P. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via toll-like receptor 2, and confers protection against lethal infection. J. Immunol. 168 (2002) 6366-6374
35. Peluffo G., Piacenza L., Irigoin F., Alvarez M.N., and Radi R. l-arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol. 20 (2004) 363-369
36. Planelles L., Thomas M., Maranon C., Morell M., and Lopez M. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clin. Exp. Immunol. 131 (2003) 41-47
37. Rodrigues M., Ribeirao M., and Boscardin S. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol. Lett. 73 (2000) 43-50
38. Ropert C., and Gazzinelli R. Regulatory role of toll-like receptor 2 during infection with Trypanosoma cruzi. J. Endotoxin Res. 10 (2004) 425-430
39. Schnapp A.R., Eickhoff C.S., Sizemore D., Curtiss III R., and Hoft D.F. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70 (2002) 5065-5074
40. Silva J., Machado F., and Martins G. The role of nitric oxide in the pathogenesis of Chagas disease. Front. Biosci. 8 (2003) s314-s325
41. Torrico F., Heremans H., Rivera M., Van Marck E., Billiau A., and Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146 (1991) 3626-3632
42. Underhill D., Ozinsky A., Hajjar A., Stevens A., Wilson C., Bassetti M., and Aderem A. The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401 (1999) 811-815
43. Underhill D.M., Bassetti M., Rudensky A., and Aderem A. Dynamic interactions of macrophages with T cells during antigen presentation. J. Exp. Med. 190 (1999) 1909-1914
44. Winston B., Krein P., Mowat C., and Huang Y. Cytokine-induced macrophage differentiation: a tale of 2 genes. Clin. Invest. Med. 22 (1999) 236-255